000 | 01056 a2200301 4500 | ||
---|---|---|---|
005 | 20250511225355.0 | ||
264 | 0 | _c19900523 | |
008 | 199005s 0 0 eng d | ||
022 | _a0883-5896 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFefer, A | |
245 | 0 | 0 |
_aBone marrow transplantation for the treatment of chronic myelogenous leukemia. _h[electronic resource] |
260 |
_bImportant advances in oncology _c1990 |
||
300 |
_a143-58 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review | ||
650 | 0 | 4 |
_aBone Marrow Transplantation _xadverse effects |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aEvaluation Studies as Topic |
650 | 0 | 4 | _aHistocompatibility |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xmortality |
650 | 0 | 4 | _aLife Tables |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 | _aTransplantation, Homologous |
700 | 1 | _aThomas, E D | |
773 | 0 |
_tImportant advances in oncology _gp. 143-58 |
|
999 |
_c2188643 _d2188643 |